|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 216.12 USD | +3.04% |
|
+0.04% | +22.80% |
| 02/07 | Biogen Says Research, Milestone Charges to Reduce Earnings in Q2, Q3 | MT |
| 01/07 | HEALTH ROUNDS-Old cancer drug may help restore fertility for certain women | RE |
| Market Cap | 31.91B 27.89B 25.63B 23.89B 45.32B 3,038B 46.01B 308B 120B 1,493B 120B 117B 5,146B | P/E 2026 * |
34.9x | P/E 2027 * | 18.1x |
|---|---|---|---|---|---|
| Enterprise Value | 37.28B 32.59B 29.95B 27.92B 52.95B 3,550B 53.75B 360B 140B 1,745B 140B 137B 6,012B | EV / Sales 2026 * |
3.71x | EV / Sales 2027 * | 3.4x |
| Free-Float |
85.96% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Biogen Inc.
| 1 day | +3.04% | ||
| 1 week | +0.04% | ||
| Current month | +0.03% | ||
| 1 month | +10.29% | ||
| 3 months | +21.87% | ||
| 6 months | +21.54% | ||
| Current year | +22.80% |
| 1 week | 209.67 |  | 219.72 |
| 1 month | 192.18 | | 219.72 |
| Current year | 160.36 | | 219.72 |
| 1 year | 121.05 | | 219.72 |
| 3 years | 110.04 | | 287.6 |
| 5 years | 110.04 | | 372.12 |
| 10 years | 110.04 | | 468.55 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 66 | 14/11/2022 | |
Robin Kramer
DFI | Director of Finance/CFO | 60 | 01/03/2025 |
Guy Hadari
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Eric Rowinsky
BRD | Director/Board Member | 69 | 23/03/2010 |
Stephen Sherwin
BRD | Director/Board Member | 77 | 01/01/2010 |
William Hawkins
BRD | Director/Board Member | 72 | 19/06/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 09/06 | Free | Director | 1,505 | 0.0010% | ||
| 09/06 | Free | Director | 1,505 | 0.0010% | ||
| 09/06 | Free | Chairman | 2,005 | 0.0014% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.04% | +0.04% | +62.66% | -24.29% | 31.91B | |
| +4.73% | +3.38% | +19.53% | -8.89% | 66.56B | |
| -1.93% | +0.39% | +58.62% | +226.33% | 56.51B | |
| +1.07% | +42.10% | +42.10% | +42.10% | 42.98B | |
| +3.45% | +6.04% | -49.46% | -55.91% | 40.46B | |
| +10.01% | +18.57% | +161.59% | -34.48% | 31.65B | |
| +2.68% | +2.73% | +70.72% | +88.24% | 23.35B | |
| +2.87% | +16.83% | +3.78% | +192.67% | 19.46B | |
| -0.13% | +2.75% | +67.48% | +130.07% | 17.18B | |
| +3.58% | +9.89% | +75.47% | +344.90% | 15.12B | |
| Average | +2.94% | +8.96% | +51.25% | +90.08% | 34.52B | |
| Weighted average by Cap. | +2.83% | +7.46% | +45.08% | +67.03% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 10.05B 8.79B 8.08B 7.53B 14.28B 957B 14.49B 96.96B 37.69B 470B 37.73B 36.92B 1,621B | 10.38B 9.08B 8.34B 7.77B 14.75B 988B 14.97B 100B 38.92B 486B 38.97B 38.13B 1,674B |
| Net income | 1.52B 1.33B 1.22B 1.14B 2.16B 145B 2.19B 14.68B 5.71B 71.24B 5.71B 5.59B 245B | 1.97B 1.72B 1.58B 1.47B 2.8B 187B 2.84B 18.99B 7.38B 92.15B 7.39B 7.23B 318B |
| Net Debt | 5.37B 4.7B 4.32B 4.02B 7.63B 511B 7.75B 51.81B 20.14B 251B 20.16B 19.73B 866B | 3.35B 2.93B 2.69B 2.51B 4.76B 319B 4.83B 32.31B 12.56B 157B 12.57B 12.3B 540B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/07/26 | USD 216.12 | +3.04% | 1,155,165 |
| 01/07/26 | USD 209.74 | -2.93% | 1,138,639 |
| 30/06/26 | USD 216.06 | -0.26% | 1,091,325 |
| 29/06/26 | USD 216.63 | +0.28% | 1,279,990 |
| 26/06/26 | USD 216.03 | +6.97% | 2,374,525 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BIIB Stock
Select your edition
All financial news and data tailored to specific country editions
